期刊文献+

吗啡与氯诺昔康复合应用对大鼠激光痛阈的影响 被引量:2

Effect of morphine combined with lornoxicam on CO_2 laser pain threshold in rats
下载PDF
导出
摘要 目的:研究不同剂量吗啡与氯诺昔康复合应用对大鼠激光痛阈的影响,探讨二者是否具有协同作用。方法:成年雄性SD大鼠42只,随机分为7组:生理盐水对照组(control),吗啡组(M),氯诺昔康组(L),合并给药组ML1、ML2、ML3组。各组大鼠分别于给药前,给药后15、30、60、120min进行痛阈测定,并计算痛阈提高百分率,以比较不同剂量的药效。依金正均法计算Q值,评价吗啡与氯诺昔康之间的相互作用。结果:各组间给药前CO2激光痛阈无显著性差异。给药后15min大鼠痛阈开始增高,30min达到峰值,较高剂量组可持续至给药后120min。计算给药后M、L、ML1组60min时痛阈提高百分率并用金正均法计算Q值,Q=1.18。结论:吗啡与氯诺昔康复合应用,在一定范围内镇痛效应随剂量增加而增大,Q值大于1.15,表明两药药效有一定的协同作用。 Objective: To study the effect of different doses of morphine combined with lomoxicam on CO2 laser pain threshold in rats and whether morphine and lornoxicam have synergistic effects. Methods: Forty-two male SD rats, weighting 200 -250g, were randomly divided into seven groups. Rats in control group received hypodermic injection of 1 mL 0.9% NaC1; rats in group M received hypodermic injection of morphine (4mg/kg) ; rats in group L received hypodermic injection of lomoxicam (4mg/kg) ; rats in groups ML1 , ML2 and ML3 received hypodermic injection of morphine combined with lornoxicam(4mg/kg & 4mg/kg, 2mg/kg & 2mg/kg, lmg/kg & lmg/kg), respectively. Pain behavior of CO2 laser was assessed at 15, 30, 60 and 120min before and after drug administration. The percentage of pain threshold was calculated. The interaction type was estimated by Q value provided by Jin Zhengjun's method. Results: The pain thresholds of rats in all groups except for control group began to increase at about 15min after drug administration and reached their peak at 30min. The effect was maintained till 120min after drug administration in groups M, ML1 and ML2. The pain thresholds of rats in groups ML1, ML2 and ML3 showed a statistical difference, and increased with the increasing dose of drugs. The analgesic effect of morphine combined with lornoxicam was significantly higher than that of morphine or lornoxiam alone. The Q value at 60min after drug administration was calculated, and Q 〉 1.15 indicated that the two drugs had significant synergistic effects. Conclusion: Morphine combined with lornoxicam provides analgesia in a dose-dependent manner. The combination of morphine and lomoxicam has synergistic effects.
出处 《军医进修学院学报》 CAS 2009年第2期126-127,132,共3页 Academic Journal of Pla Postgraduate Medical School
基金 "十一五"军队医药卫生科研基金项目(06Z051)~~
关键词 吗啡 氯诺昔康 镇痛 药物协同作用 morphine lornoxicam analgesia drug synergism
  • 相关文献

参考文献6

  • 1Staunstrup H, Oveser J, Larsen UT, et al. Efficacy and tolerability of lornoxieam versus tramadol in postoperative pain [ J ]. J Clin pharmacol, 1999, 39 (8) :834-841.
  • 2Alexander R, EI-Moalem HE, Gan TJ. Comparison of the mor-phine-sparing effects of diclofenac sodium and ketorolac tromethamine after major orthopedic surgery [J]. J Clin Anesth, 2002, 14(3) :187-192.
  • 3徐江玲.氯诺昔康复合吗啡用于术后静脉镇痛[J].中原医刊,2005,32(22):34-35. 被引量:4
  • 4Greco WR, Bravo G, Parsons JC. The search for synergy:a critical review from a response surface perspective [ J ]. Pharmacol Rev, 1995, 47(2) :331-385.
  • 5王心,辛晓燕,黄艳红.染料木黄酮对卵巢癌HO-8910PM裸鼠移植瘤的抑制作用[J].第四军医大学学报,2006,27(6):536-539. 被引量:5
  • 6金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.

二级参考文献17

  • 1刘肖平.非甾体抗炎药与术后多模式互补镇痛[J].国外医学(麻醉学与复苏分册),1996,17(4):193-195. 被引量:38
  • 2Pruss TP,Stroissnig H,Radhofer-Welte S,et al.Overview of the pharmacological properties,pharmacokinetics and animal safety assessment of lomoxicam.Postgrad med J,1990,66(4):18~21.
  • 3Olkkola KT,Brunetto AV,Mattila MJ.Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.Clinpharmacokinet,1994,26:107~120.
  • 4Hitzenberger G,Radhofer-Welte S,Takace F,et al.Pharmackinetics of lornoxicam in man.Postgrad Med J,1990,66(4):S22~27.
  • 5Kullich w,klein G,Influence of the nonsteroidal anti-inflammatory drug lornoxicam iv on the secretion of the endogenous opiate peptides dynorphin and endorphin.Aktuel Rheumatol,1992,17:128~132.
  • 6Norholt SE,Sindet-Pedersen S,Larsen U,et al.Pain control after dental surgery:a double-blind,randomized trial of lornoxicam versus morphine.Pain,1996,67:335~343.
  • 7Baker CH, Solorzano CC, Fidler IJ. Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer[ J]. Cancer Res,2002,62 (7) : 1996 - 2003.
  • 8Waga S, Hannon GJ, Beach D, et al. The p21 inhibitor of cyclindependent kinases controls DNA replication by interaction with PCNA[J]. Nature, 1994,369(6481 ) :574 -578.
  • 9Dieras V, Guastalla JP, Ferrero JM, et al. A multicenter phase Ⅱ study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study[J]. Cancer Chemother Pharmacol, 2004,53(6) :489 -495.
  • 10Ekborn A, Hansson J, Ehrsson H, et al. High-dose Cisplatin with amifostine : ototoxicity and pharmacokinetics [ J ]. Laryngoscope,2004,114(9) :1660-1667.

共引文献124

同被引文献28

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部